Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
40 Cards in this Set
- Front
- Back
What antibodies are in RA are against |
IgG-Fc Citrullinated proteins Collagen type II |
|
How do you get T cell activation |
Apc present antigen to CD4 cells move to Th0 naive t cell then move into Th2 lineage |
|
How to get the B cell to make antibodies |
Apc present to CD4 cell then to Th0 then Th2 lineage which produces IL-4 to help mature B cell then to antibodies |
|
How do Th1 cause inflammation |
Produce IFNy and TNFa |
|
How does Th17 move to inflammation |
Produce Il-17 |
|
Th1 lineage deals with what |
Viral infection |
|
What does th2 lineage fight against |
extracellular pathogen Asthma is a Th2 response |
|
What role does B cells play |
Important role in antibody production and in activating T crlls through antigen presentation |
|
How is complement activated |
Through antigen/antibody/c1 complex) |
|
What is rankl and what does it do |
Its a ligand that stimulates osteoclast which is bone erosion |
|
What do cytokines fo to the fibroblast |
Activate the synovial fibroblast so they proliferate, then release MMP(matrix metalproteases) they dissolve matrix |
|
What do fibroblasts do |
Replace cartilage lose of function then and replacing it with something that isnt functional |
|
Name cellular events in RA |
Inflammation occurs- inc blood flow to joint, leakiness and swelling::Increased expression of adhesion molecules and influx of white blood cells into the joint T and b cells and macrophages Macrophages activate to produce 2 major cytokines TNFa and IL-1b Stumulate to induce COX-2 and increase PGEs(pain and more inflammation) Stimulated to release chemo-attractants and attract more cells to joint |
|
What does TNFa do |
Stimulates synoviocytes (fibroblast like cells in the joint) |
|
What do tnfα and IL-1β do |
Stimulates the Sinoviocytes to proliferate As a ressult the cartilage gets replaced with fibroblasts non-functional – disaster |
|
What does il-17 stimulate |
Macrophages and synoviocytes in the joint to release cytokines such as IL-6 |
|
Th17 cells produce what |
RANKL molecule which interacts with the receptor RANK cause the activation of osteoclasts- they destroy bone Bone is broken down, further destruction and damage to the joint |
|
Cells in the joint release what and what does this do |
IL-3, GM-CSF and G-CSF These molecules tell the bone marrow to make more of leukocytes Leucocytes are directed into inflamed joint synovium |
|
Joint destruction involves what |
Slow growth of synovial tissue onto the articular surface( no sponginess just grating) Sustained release of PGs and LTs Pain and oedema Fused joint |
|
Delays in treatment of RA can result in what |
Long term joint damage |
|
What can early intensive treatment of RA do |
Increase chances of halting or slowing disease progression |
|
What drugs can treat RA |
NSAIDs DMARDs Glucocorticoids |
|
Name some NSAIDs |
Asprin, indomethacin, ibuprofen, diclofenac |
|
What do NSAIDs block at |
COX |
|
Whats the 2 forms cox exists as |
COX-1 and COX-2 |
|
What is the characteristics for COX-1 |
constitutive Involved in normal physiology e.g g.i tract, lungs, kidneys, vascular endothelium, platelets |
|
Cox-2 characteristics |
Inducible Induced in inflammed tissue |
|
What are classical NSAIDS |
non selective binding both COX-1 and COX-2 with most showing some moderate or marked preference for COX-1 |
|
Whats some COX-2 selective inhibitors |
Celecoxib, refecoxib and eterocoxib |
|
What does asprin trigger |
Formation of lipoxins- asprin triggered lipoxin (ATL) and resolvins via COX-2 |
|
Asprin acetylating COX-2 dors what |
Acetylated COX-2 converts eicosapentanoic(EPA) to 18R-HEPE which is then converted by 5-LOX to resolvin E1 |
|
Indomethacin and diclofenac inhibit what |
Degradation of resolvins/lipoxins |
|
Whats the therapeutic effects of NSAIDS |
reduce pain Reduce inflammation-pain, vasodilation, increased vascular permeability-swelling reduced Reduce morning joint stiffness Antipyretic Effectively reduce symptoms but do not modify underlying disease process |
|
Where are the adverse effects of using NSAIDS |
Gi tract Kidney Lung Cardiovascular system |
|
What is asprin-induced asthma |
Common High cross-reactivity (up to 100%) with other NSAIDs Push pathway towards the production of leukotrienes |
|
Cox-2 inhibitors have what |
Therapeutic action of NSAIDs but without gi adverse effects |
|
When should COX-2 inhibitors be cautiously used |
In patients with pre existing peptic ulcer disease |
|
When is COX-2 inhibitors a problem |
Increased cardiovascular mortality |
|
What are the cardiovascular effects of NSAIDs |
Increased risk of MI Increased risk of stroke Varies among compounds Relative potency for COX-1 verus cox-2?? Not COX-2 related |
|
What happen with Merck and Vioxx |
Vioxx was a COX-2 inhibitor Kept all data about CV Problems quiet Responsible for 1000 of deaths in the US |